National Health Investors (NYSE:NHI) Releases FY24 Earnings Guidance

National Health Investors (NYSE:NHI - Get Free Report) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $4.37-4-43 for the period, compared to the consensus estimate of $4.35.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft began coverage on National Health Investors in a research note on Tuesday, January 30th. They issued a buy rating and a $69.00 price target for the company. StockNews.com downgraded shares of National Health Investors from a buy rating to a hold rating in a research report on Thursday, April 18th. BMO Capital Markets raised shares of National Health Investors from a market perform rating to an outperform rating and set a $67.00 price objective on the stock in a research note on Tuesday, March 12th. Wells Fargo & Company raised shares of National Health Investors from an equal weight rating to an overweight rating and lifted their target price for the stock from $55.00 to $63.00 in a research note on Monday, February 26th. Finally, Wedbush upped their price target on shares of National Health Investors from $64.00 to $66.00 and gave the company an outperform rating in a research report on Monday, March 18th. Five equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of Hold and a consensus target price of $60.50.

National Health Investors Stock Up 2.2 %

NHI stock traded up $1.41 during midday trading on Tuesday, reaching $65.66. 311,091 shares of the company's stock traded hands, compared to its average volume of 171,351. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.90. The firm's fifty day moving average price is $60.67 and its 200-day moving average price is $56.36. National Health Investors has a 52 week low of $48.51 and a 52 week high of $66.10. The company has a market cap of $2.85 billion, a price-to-earnings ratio of 20.63 and a beta of 0.95.

National Health Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 2nd. Investors of record on Friday, June 28th will be issued a $0.90 dividend. The ex-dividend date is Friday, June 28th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.48%. National Health Investors's dividend payout ratio is presently 115.02%.

Insider Buying and Selling at National Health Investors

In related news, Director Charlotte A. Swafford purchased 10,000 shares of the firm's stock in a transaction that occurred on Tuesday, February 27th. The stock was acquired at an average price of $58.69 per share, for a total transaction of $586,900.00. Following the completion of the acquisition, the director now owns 110,185 shares of the company's stock, valued at approximately $6,466,757.65. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 8.21% of the company's stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.